全文获取类型
收费全文 | 1301篇 |
免费 | 74篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 41篇 |
妇产科学 | 5篇 |
基础医学 | 140篇 |
口腔科学 | 29篇 |
临床医学 | 143篇 |
内科学 | 197篇 |
皮肤病学 | 10篇 |
神经病学 | 92篇 |
特种医学 | 33篇 |
外科学 | 332篇 |
综合类 | 17篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 107篇 |
眼科学 | 26篇 |
药学 | 98篇 |
中国医学 | 36篇 |
肿瘤学 | 67篇 |
出版年
2024年 | 4篇 |
2023年 | 15篇 |
2022年 | 42篇 |
2021年 | 59篇 |
2020年 | 33篇 |
2019年 | 60篇 |
2018年 | 52篇 |
2017年 | 32篇 |
2016年 | 39篇 |
2015年 | 42篇 |
2014年 | 47篇 |
2013年 | 64篇 |
2012年 | 99篇 |
2011年 | 86篇 |
2010年 | 50篇 |
2009年 | 55篇 |
2008年 | 101篇 |
2007年 | 101篇 |
2006年 | 75篇 |
2005年 | 49篇 |
2004年 | 60篇 |
2003年 | 45篇 |
2002年 | 49篇 |
2001年 | 9篇 |
2000年 | 13篇 |
1999年 | 10篇 |
1998年 | 12篇 |
1997年 | 8篇 |
1996年 | 2篇 |
1995年 | 4篇 |
1994年 | 4篇 |
1993年 | 9篇 |
1992年 | 2篇 |
1991年 | 4篇 |
1990年 | 4篇 |
1989年 | 4篇 |
1987年 | 2篇 |
1986年 | 2篇 |
1984年 | 2篇 |
1983年 | 2篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1974年 | 5篇 |
1973年 | 2篇 |
1970年 | 1篇 |
1965年 | 1篇 |
1960年 | 1篇 |
1959年 | 2篇 |
排序方式: 共有1378条查询结果,搜索用时 333 毫秒
981.
Naik NA Bhat IA Afroze D Rasool R Mir H Andrabi SI Shah S Siddiqi MA Shah ZA 《Tumour biology》2012,33(3):833-839
The vascular endothelial growth factor (VEGF) is a major mediator of angiogenesis involving tumor growth and metastasis. Polymorphisms
in the VEGF gene may regulate VEGF production. In this case–control study, we investigated whether functional polymorphisms
(+405 C > G and +936 C > T) in the VEGF gene are associated with the risk of lung cancer. Genomic DNA was isolated from the
blood of 100 lung cancer patients and 150 healthy controls, and total RNA was isolated from 48 tumor tissues and adjacent
normal lung tissues. Two DNA polymorphisms (+405 C > G and +936 C > T) in the 3′-untranslated regions (3′-UTR) and 5′-untranslated
regions (5′-UTR) of vascular endothelial growth factor A (VEGFA) were studied using PCR–RFLP method, and mRNA expression of
VEGFA was studied by quantitative real-time PCR. Polymorphisms in the 5′-UTR (+405 C > G) and 3′-UTR (+936 C > T) did not
show significant difference between lung cancer cases and control samples (P = 0.11 and P = 0.09, respectively). VEGF +405 CG and GG are significantly more in age group >50 years old, in all grades, and in early
pathological stages (P = 0.04, P = 0.03, and P = 0.006, respectively). Also, increased expression of VEGFA mRNA was noted in tumorous compared to non-tumorous tissue (P < 0.0001). Overexpression of the gene was considered at ΔC
T > 6.0. Within the group of patients with conventional tumor, those with histology other than squamous cell carcinoma (SCC)
had a higher level of VEGFA mRNA expression than SCC patients (P = 0.04). Overexpression of VEGFA mRNA was noted in lung cancer and more so in lung cancer with adenocarcinoma and large cell
carcinoma histology and in pathological stages III and IV. VEGFA +405 C > G SNP showed an association with age, pathological
grade, and stage. 相似文献
982.
Schwerzmann M Zafar M McLaughlin PR Chamberlain DW Webb G Granton J 《International journal of cardiology》2006,110(1):104-107
The presence of irreversible pulmonary hypertension in patients with atrial septal defect (ASD) is thought to preclude shunt closure. We report the case of a woman with plexiform pulmonary arteriopathy secondary to an ostium secundum ASD who was able to successfully undergo percutaneous shunt closure following therapy with chronic intravenous prostacyclin (Flolan). One year after closure, the patient was weaned off Flolan over a period of 7 months following the institution of oral Bosentan therapy. Our case illustrates how aggressive vasodilator therapy with prostaglandins may be capable of reducing pulmonary artery pressure and permitting shunt closure in a patient once considered to have "inoperable" pulmonary arteriopathy. 相似文献
983.
Strickler JH Starodub AN Jia J Meadows KL Nixon AB Dellinger A Morse MA Uronis HE Marcom PK Zafar SY Haley ST Hurwitz HI 《Cancer chemotherapy and pharmacology》2012,70(2):251-258
Purpose
To define the maximum tolerated dose, clinical toxicities, and pharmacodynamics of bevacizumab, everolimus, and panobinostat (LBH-589) when administered in combination to patients with advanced solid tumor malignancies.Experiment design
Subjects received 10?mg of panobinostat three times weekly, 5 or 10?mg everolimus daily, and bevacizumab at 10?mg/kg every 2?weeks. Dose-limiting toxicities (DLTs) were assessed in cycle 1; toxicity evaluation was closely monitored throughout treatment. Treatment continued until disease progression or undesirable toxicity. Protein acetylation was assessed in peripheral blood mononuclear cells (PBMC) both at baseline and on treatment.Results
Twelve subjects were evaluable for toxicity and nine subjects for response. DLTs in cohort 1 included grade 2 esophagitis and grade 3 oral mucositis; DLTs in cohort -1 were grade 2 ventricular arrhythmia and grade 2 intolerable skin rash. Common adverse events were diarrhea (50?%), headache (33?%), mucositis/stomatitis (25?%), hyperlipidemia (25?%), and thrombocytopenia (25?%). There was 1 partial response; an additional 2 subjects had stable disease as best response. No consistent changes in protein acetylation in PBMC were observed in samples available from eight patients on treatment compared with baseline.Conclusions
Bevacizumab, everolimus, and panobinostat in combination at the lowest proposed doses did not have an acceptable safety and tolerability profile and did not consistently inhibit HDAC activity; therefore, we do not recommend further evaluation. 相似文献984.
Recent findings from the perirhinal cortex have shed new light on the ways in which metabotropic glutamate receptors could be involved in synaptic plasticity, and in particular in long-term depression (LTD) of synaptic transmission. Importantly, these findings have also led to a greater understanding of mechanisms that could regulate mglu-receptor signalling and the ways in which mglu receptors interact with one another. 相似文献
985.
986.
987.
988.
Naseem A Aftab PA Zafar N 《Journal of the College of Physicians and Surgeons--Pakistan : JCPSP》2006,16(2):145-147
Necrotizing fasciitis (NF) in an immunocompetent patient with multiple sites of involvement is very rare. We describe a case of E. coli associated necrotizing fasciitis in a middle aged female with three lesions of NF on her lower limbs at the time of presentation. She was managed with broad spectrum intravenous antibiotics, radical surgical debridements with skin grafting, and aggressive supportive care. 相似文献
989.
990.
Zafar M Mehmood A Abassi MH Shah SS 《Journal of the College of Physicians and Surgeons--Pakistan : JCPSP》2006,16(6):424-425
We report a case of non-Hodgkin's lymphoma (NHL) in 23 years old, 36 weeks pregnant female, who presented with a swelling in the vagina. Biopsy of the lesion led to profuse haemorrhage and emergency caesarean-section along with bilateral ligation of internal iliac arteries were required. Recovery was smooth and she was discharged from the hospital on the 5th postoperative day. Histopathology revealed non-Hodgkin's lymphoma, diffuse large B cell type (DLBCL). Further treatment by medical oncologist led to complete resolution of the tumour at three months. 相似文献